{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 0, "question": "What is the demographic breakdown of employees working in the Asia-Pacific region?", "prediction": "Based on the provided chunks, there is no specific information about the demographic breakdown of employees in the Asia-Pacific region. The text mentions an Asian & Pacific Islanders Business Resource Network (BRN), but does not provide detailed demographic data for employees in that region.", "ground_truth": "The financial statement does not provide information on the demographic breakdown of employees working in the Asia-Pacific region."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 1, "question": "What are the company's specific strategies for expanding into the Asian market?", "prediction": "Based on the provided chunks, there are no specific details about strategies for expanding into the Asian market. The chunks discuss international expansion in general terms, mentioning plans to expand globally and attract international learners, but do not provide specific strategies for Asia. The closest reference is a broad statement about expanding internationally through the edX acquisition and wanting to add top-tier international universities, but no Asia-specific approach is outlined.", "ground_truth": "The financial statement does not mention any specific strategies for expanding into the Asian market."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 2, "question": "What percentage of the university clients have opted for performance-based compensation agreements?", "prediction": "I apologize, but there is no specific information in these financial statement chunks that indicates the percentage of university clients with performance-based compensation agreements. The documents describe the compensation structure and revenue recognition methods, but do not provide a precise percentage of clients using such arrangements.", "ground_truth": "The financial statement does not provide information on the percentage of university clients that have opted for performance-based compensation agreements."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 3, "question": "What is the company's projected revenue for 2024?", "prediction": "I apologize, but there is no information in the provided financial statement chunks that projects the company's revenue for 2024. The chunks provide historical revenue information and discuss various financial and operational aspects of the company, but do not include a specific revenue forecast for the upcoming year.", "ground_truth": "The financial statement does not provide any projections or estimates for the company's revenue in 2024."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 4, "question": "What is the company's strategy for entering new geographic markets?", "prediction": "Based on the chunks, the company's strategy for entering new geographic markets involves:\n\n1. Leveraging edX's existing global web traffic and large non-US learner base\n2. Expanding offerings with top-tier international universities\n3. Attracting additional non-US learners to existing offerings\n\nThey recognize challenges like localizing content, navigating different regulatory environments, and managing international operations, but see international expansion as a key part of their growth strategy.", "ground_truth": "The financial statement does not provide information on the company's strategy for entering new geographic markets."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 5, "question": "What are the projected interest expenses for 2024?", "prediction": "Based on the provided chunks, there is no specific projection of interest expenses for 2024. The chunks detail some interest-related information like the 2025 Notes having a 2.25% interest rate and $10.6 million in interest expense for 2022 and 2023, but do not provide a forward-looking interest expense estimate for 2024.", "ground_truth": "The financial statement does not provide projections for interest expenses in 2024."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": "full", "question": "What is 2U, Inc.'s strategy for entering emerging markets in the next five years?", "prediction": "I apologize, but I cannot find specific information about 2U, Inc.'s strategy for entering emerging markets in the next five years within these financial statement chunks. The documents provide details about the company's current operations, segments, and human capital, but do not outline a forward-looking market expansion strategy for emerging markets. To accurately answer this question, I would need additional strategic planning documents or sections of the financial report not included in these excerpts.", "ground_truth": "The financial statement does not mention 2U, Inc.'s strategy for entering emerging markets in the next five years."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 0, "question": "What are the specific sustainability initiatives the company is focusing on for 2023?", "prediction": "Based on the provided chunks, there are no specific sustainability initiatives detailed for 2023. The chunks mention that sustainability initiatives can be found on the company's website (www.3DSystems.com), but no concrete details about sustainability efforts for 2023 are provided in these excerpts. The text does discuss some strategic initiatives like expanding additive manufacturing and investing in regenerative medicine, but these are not explicitly framed as sustainability initiatives.", "ground_truth": "The document does not provide specific details about the company's sustainability initiatives for 2023."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 1, "question": "What are the future trends expected in the additive manufacturing industry?", "prediction": "Based on the provided chunks, here are the key future trends expected in the additive manufacturing industry:\n\n1. Increased adoption of additive manufacturing in production environments across various industries, including healthcare, aerospace, defense, and general manufacturing.\n\n2. Expansion of software and digital workflow solutions that leverage technologies like:\n- Cloud-based platforms\n- Industrial Internet of Things (IoT)\n- Artificial Intelligence\n- Machine learning\n\n3. Focus on enabling customers to:\n- Solve design and manufacturing challenges\n- Improve lead times\n- Enhance design freedom\n- Enable mass customization\n- Scale production capabilities\n\n4. Growing emphasis on integrated solutions that combine hardware, materials, software, and professional services to create comprehensive additive manufacturing ecosystems.\n\n5. Continued investment in advanced manufacturing technologies, particularly in medical applications and high-performance materials.", "ground_truth": "The document does not provide any information on future trends expected in the additive manufacturing industry."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 2, "question": "What are the specific strategies for expansion in the Asia-Pacific region for the upcoming fiscal year?", "prediction": "Based on the provided financial statement chunks, there are no specific details about 3D Systems' expansion strategies for the Asia-Pacific (APAC) region in the upcoming fiscal year. While the document mentions APAC as one of their market regions, it does not outline any specific growth plans for that geographic area. The text focuses more on overall company strategy, such as focusing on Healthcare and Industrial Solutions, and making selective acquisitions, but does not provide region-specific expansion details.", "ground_truth": "The financial statement does not mention any specific strategies for expansion in the Asia-Pacific region for the upcoming fiscal year."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 3, "question": "What is the projected growth rate for the company's industrial solutions segment over the next five years?", "prediction": "I apologize, but I cannot find a specific five-year projected growth rate for the industrial solutions segment in the provided financial statement chunks. While the document discusses the industrial solutions segment and provides some historical financial information, it does not include a forward-looking growth projection for the next five years.", "ground_truth": "The document does not provide any projected growth rate for the company's industrial solutions segment over the next five years."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 4, "question": "What is the company's dividend payout ratio for the year ended December 31, 2022?", "prediction": "Based on the provided financial statement chunks, the company did not declare any dividends in the year ended December 31, 2022. Therefore, the dividend payout ratio is 0.", "ground_truth": "The document does not provide information on the company's dividend payout ratio for the year ended December 31, 2022."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 5, "question": "How does the company plan to allocate its research and development budget for the next fiscal year?", "prediction": "Based on the provided financial statement chunks, there is no explicit information about the company's specific research and development budget allocation for the next fiscal year. The chunks provide historical information about R&D expenses, showing an increase of $17.9 million (25.9%) in fiscal year 2022, driven by acquisitions and increased compensation and operating supplies. However, they do not outline future R&D budget plans or strategy.", "ground_truth": "The document does not mention any specific plans for the allocation of the research and development budget for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": "full", "question": "What is the expected completion date for the Oqton software integration into the Oqton Manufacturing Operating System?", "prediction": "Based on the provided chunks, there is no specific completion date mentioned for the Oqton software integration. The text only indicates that 3D Systems is \"working to integrate 3D System's legacy stand-alone software applications into Oqton's legacy MOS\" to offer a complete cloud-based software solution, but no timeline is provided.", "ground_truth": "The financial report does not provide a specific expected completion date for the Oqton software integration into the Oqton Manufacturing Operating System."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 0, "question": "What were the results of the company's environmental sustainability initiatives?", "prediction": "Based on the provided chunks, the company has set a goal to achieve net zero carbon for operations by 2030 as part of their Environmental, Social, and Governance (ESG) strategy. However, the text explicitly states that they \"cannot guarantee that we will make progress on our commitments and initiatives or achieve our goals.\" No specific results of their environmental sustainability initiatives are detailed in these chunks.", "ground_truth": "The financial statement does not mention or provide any details about the results of the company's environmental sustainability initiatives."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 1, "question": "What is the expected timeline for the integration of Afterpay with the company's systems?", "prediction": "Based on the provided chunks, there is no specific detailed timeline mentioned for the full integration of Afterpay with Block's systems. The only specific date mentioned is October 31, 2023, when certain U.S. Afterpay entities were integrated into Block's U.S. federal consolidated filing group for tax purposes. The integration is described as aimed at improving tax compliance efficiencies and optimizing funding opportunities, but no comprehensive systems integration timeline is provided.", "ground_truth": "The financial statement does not specify an expected timeline for the integration of Afterpay with the company's systems."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 2, "question": "What specific strategies are in place for integrating new acquisitions into the current business model?", "prediction": "Based on the provided chunks, the company has the following strategies for integrating new acquisitions:\n\n1. Enhance internal controls and reporting systems for new lines of business\n2. Implement internal controls specific to acquired businesses\n3. Utilize professional services and consulting fees to integrate acquired businesses\n4. Redeem acquirees' unvested share-based compensation awards\n5. Conduct legal, accounting, valuation, and due diligence processes for business combinations\n\nThe acquisition of Afterpay is specifically mentioned as a strategic move to strengthen the company's position in delivering financial products and services. The company appears to have a structured approach to carefully evaluate and integrate new acquisitions while maintaining operational efficiency.", "ground_truth": "The financial statement does not provide details about specific strategies for integrating new acquisitions into the business model."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 3, "question": "What strategies has the company implemented to reduce the impact of Bitcoin price volatility on its profits?", "prediction": "Based on the provided chunks, the company has implemented several strategies to mitigate Bitcoin price volatility:\n\n1. Accounting Method: The company early adopted ASU 2023-08, which allows them to:\n- Remeasure Bitcoin at fair value each reporting period\n- Recognize changes in fair value directly in net income\n- Avoid permanent impairment restrictions (previously, value increases couldn't be recovered until sale)\n\n2. Investment Approach:\n- Holds Bitcoin for long-term investment purposes\n- Uses first-in, first-out method for cost basis tracking\n- Recognizes gains/losses from Bitcoin remeasurement in \"Other income, net\"\n\n3. Risk Management:\n- Limits Bitcoin holdings for operating purposes\n- Quickly trades Bitcoin for customer orders (typically within a day)\n- Acknowledges and monitors market risks in financial disclosures\n\nThese strategies help the company maintain financial flexibility and transparency regarding its Bitcoin investments while mitigating potential negative impacts from price volatility.", "ground_truth": "The financial statement does not detail any specific strategies the company has implemented to reduce the impact of Bitcoin price volatility on its profits."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 4, "question": "How does the company plan to diversify its hardware product offerings in 2024?", "prediction": "Based on the provided chunks, there is no specific information about the company's plans to diversify hardware product offerings in 2024. The chunks describe existing hardware products like magstripe readers, contactless and chip readers, Square Stand, Square Register, Square Terminal, and third-party peripherals, but do not outline any expansion or diversification strategy for hardware in the coming year.", "ground_truth": "The financial statement does not provide specifics on plans to diversify hardware product offerings in 2024."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 5, "question": "What is the company's strategy for expanding its bitcoin holdings in the next fiscal year?", "prediction": "Based on the provided financial statement chunks, there is no explicit strategy mentioned for expanding bitcoin holdings in the next fiscal year. The chunks primarily describe the company's current bitcoin holdings, accounting methods, and how they manage bitcoin for investment and operating purposes. The company has purchased approximately $220.0 million in bitcoin for investment purposes as of December 31, 2023, but no forward-looking expansion strategy is detailed in these excerpts.", "ground_truth": "The document does not provide any information regarding the company's strategy for expanding its bitcoin holdings in the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": "full", "question": "What strategies are implemented to increase customer acquisition within the TIDAL ecosystem?", "prediction": "Based on the provided chunks, there are no specific strategies detailed for customer acquisition within the TIDAL ecosystem. The chunks only provide general information about TIDAL, such as it being a global platform with 132 million songs and listeners in over 60 countries. The text acknowledges challenges in competing for listeners but does not outline specific acquisition strategies. In fact, chunk 2 suggests potential difficulties in growing the TIDAL business, noting that continued investment does not guarantee success.", "ground_truth": "The document does not provide information regarding specific strategies implemented to increase customer acquisition within the TIDAL ecosystem."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 0, "question": "What are the specific future growth strategies for the Australian market?", "prediction": "After carefully reviewing the provided chunks, I cannot find any specific details about growth strategies for the Australian market. The only mention of Australia is in chunk 4, which simply shows that C.H. Robinson has 441 total employees in Oceania (which includes Australia), but provides no strategic insights about future growth in that specific market.", "ground_truth": "The document does not specify any future growth strategies for the Australian market."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 1, "question": "What is the company's policy regarding remote work for its employees?", "prediction": "Based on the provided chunks, there is no explicit detailed policy about remote work. The only related mention is in chunk 1, which briefly notes \"flexibility in where employees work\" as one of the top drivers for employee retention. However, no specific remote work policy is elaborated upon in these excerpts.", "ground_truth": "The financial statement does not mention the company's policy regarding remote work for its employees."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 2, "question": "How many new customers did C.H. Robinson acquire in 2023?", "prediction": "The document does not specify the exact number of new customers C.H. Robinson acquired in 2023. It only mentions that in 2023, they served more than 90,000 customers worldwide, ranging from Fortune 100 companies to small businesses, and that they have grown by adding new customers in recent years.", "ground_truth": "The financial statement does not provide information on the number of new customers acquired by C.H. Robinson in 2023."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 3, "question": "What were the primary drivers for the change in operating cash flows between 2021 and 2023?", "prediction": "Based on the chunks, the primary drivers for the change in operating cash flows between 2021 and 2023 were:\n\n1. Weak freight demand in 2023\n2. Excess carrier capacity\n3. Declining transportation rates\n4. Sequential declines in net operating working capital\n\nThe operating cash flow dropped from $1,650,171,000 in 2022 to $731,946,000 in 2023, primarily due to reduced net income caused by challenging market conditions in the freight and transportation industry.", "ground_truth": "The financial statement does not provide specific details on the primary drivers for the change in operating cash flows between 2021 and 2023."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 4, "question": "What are the environmental sustainability initiatives undertaken by the company?", "prediction": "Based on the retrieved chunks, C.H. Robinson's environmental sustainability initiatives include:\n\n1. Reducing greenhouse gas emissions:\n- Set a science-aligned goal to reduce Scope 1 and 2 carbon intensity by 40% by 2025\n- Achieved 47% reduction in emissions intensity by 2023\n\n2. Helping customers meet sustainability goals:\n- Using Emissions IQ™ to measure Scope 3 transportation emissions\n- Consulting on supply chain optimization to reduce empty miles\n- Helping eliminate road transportation emissions\n\n3. Industry sustainability efforts:\n- Collaborating with non-profit and academic institutions\n- Sponsoring research and participating in transportation industry innovation working groups\n\n4. Specific subsidiary initiatives:\n- Robinson Fresh focuses on reducing food waste and using sustainable packaging\n\nThe company tracks and reports on Scope 1, 2, and 3 emissions in their annual ESG report.", "ground_truth": "The financial statement does not mention any specific environmental sustainability initiatives undertaken by the company."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 5, "question": "What are the details regarding the company's latest innovation in logistics technology?", "prediction": "Based on the retrieved chunks, the company's latest innovations in logistics technology include:\n\n1. Procure IQ®: An algorithm-based tool that helps shippers find the optimal way to purchase transportation in their shipping lanes using the industry's largest freight shipment dataset.\n\n2. Emissions IQ®: A tool that provides instant visibility into carbon emissions and suggests reduction opportunities.\n\n3. Market Rate IQ™: A tool that reveals patterns in spot freight to help increase savings.\n\n4. Navisphere platform innovations:\n- Navisphere Vision™: Provides global freight visibility across modes and services\n- Navisphere Insight™: Transforms raw freight data into actionable insights\n- Navisphere Optimizer™: Minimizes travel time and maximizes trailer utilization\n\nThese technologies are part of the company's commitment to investing in data, analytics, and technology to solve complex logistics challenges.", "ground_truth": "The document does not provide any details regarding the company's latest innovation in logistics technology."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": "full", "question": "What strategies does C.H. Robinson plan to implement to expand its presence in South America beyond its current operations?", "prediction": "Based on the provided chunks, there is no specific information about C.H. Robinson's strategies to expand its presence in South America. The chunks discuss the company's current operations, employee count, and diversity initiatives, but do not outline any expansion plans for the South American region. To accurately answer this question, additional information would be needed.", "ground_truth": "The financial statement does not mention any specific strategies C.H. Robinson plans to implement to expand its presence in South America beyond its current operations."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 0, "question": "What were the specific research and development costs related to the MRD test in 2023?", "prediction": "Based on the provided chunks, there is no specific breakdown of research and development costs exclusively for the MRD test in 2023. The chunks provide details about the MRD test's development and goals, but do not isolate its specific R&D expenses. The total research and development expenses for 2023 were $425.9 million, but this covers all R&D activities, not just the MRD test.", "ground_truth": "The financial statement does not disclose specific research and development costs related to the MRD test for the year 2023."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 1, "question": "What is the company's strategy for entering the African market?", "prediction": "Based on the provided chunks, there is no specific mention of a strategy for entering the African market. The text discusses the company's general business priorities for 2024, which include focusing on people and customers, advancing test portfolios, and expanding screening access to underserved populations, but does not specifically address the African market.", "ground_truth": "The financial statement does not mention any strategy for entering the African market."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 2, "question": "What is the projected cash flow from operations for the next fiscal year?", "prediction": "Based on the provided financial statement chunks, there is no explicit projection of cash flow from operations for the next fiscal year. The statement indicates the company expects its current cash and cash equivalents will be sufficient to fund operations for at least the next twelve months, but does not provide a specific cash flow projection.", "ground_truth": "The financial statement does not provide information about the projected cash flow from operations for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 3, "question": "What is the company's plan for diversifying its product portfolio in 2024?", "prediction": "Based on the chunks, Exact Sciences plans to focus on advancing new tests in its highest priority programs in 2024, specifically:\n\n1. Colorectal cancer screening\n2. Minimal Residual Disease (MRD)\n3. Multi-Cancer Early Detection (MCED) tests\n\nThey intend to continue investing in clinical trials to enhance existing products and bring new products to patients, including obtaining FDA approval for their next-generation Cologuard test and developing a blood-based MCED test using licensed technology from Johns Hopkins University.", "ground_truth": "The financial statement does not mention any specific plans for diversifying the company's product portfolio in 2024."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 4, "question": "What are the company's projected capital expenditures for the next fiscal year?", "prediction": "According to the financial statement, the company expects to incur approximately $150.0 million in capital expenditures in 2024.", "ground_truth": "The financial statement does not provide any information on the company's projected capital expenditures for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 5, "question": "What is the projected impact of inflation on the company's leasing expenses?", "prediction": "Based on the provided financial statement chunks, there is no explicit discussion or projection of inflation's impact on the company's leasing expenses. The lease-related disclosures provide detailed information about lease costs, cash flows, and accounting methods, but do not specifically address potential inflationary effects on future lease expenses.", "ground_truth": "The financial statement does not provide any information on the projected impact of inflation on the company's leasing expenses."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": "full", "question": "What is the projected market share growth for the next-generation Cologuard test?", "prediction": "Based on the provided chunks, there is no specific projection of market share growth for the next-generation Cologuard test. The documents discuss the test's development and FDA submission in December 2023, including its improved sensitivity (94%) and specificity (91%), but do not provide a market share growth forecast.", "ground_truth": "The financial statement does not provide information regarding the projected market share growth for the next-generation Cologuard test."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 0, "question": "What was the average salary of the employees in the company during the fiscal year?", "prediction": "Based on the provided financial statement chunks, there is no specific information about the average salary of employees. While the document discusses employee benefits, compensation programs, and headcount (240 full-time employees as of December 31, 2023), it does not disclose the average salary for the fiscal year.", "ground_truth": "The financial statement does not provide information on the average salary of the employees in the company during the fiscal year."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 1, "question": "What are the specific budget allocations for employee training and development programs?", "prediction": "I apologize, but after carefully reviewing the provided financial statement chunks, I cannot find any specific details about budget allocations for employee training and development programs. The text discusses various aspects of the company's financials, stock compensation, leases, and research expenses, but does not provide a breakdown of employee training budgets.", "ground_truth": "The financial statement does not provide specific budget allocations for employee training and development programs."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 2, "question": "What are the preferred interest rates on loans provided by third-party payors?", "prediction": "I apologize, but there is no information in these financial statement chunks about loan interest rates from third-party payors. The text discusses third-party payors in the context of healthcare insurance coverage and reimbursement for medical products, not loan provision. The passages focus on how third-party payors determine coverage and reimbursement for pharmaceutical products.", "ground_truth": "The financial statement does not mention preferred interest rates on loans provided by third-party payors."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 3, "question": "What are the projected R&D expenses for the next fiscal year?", "prediction": "According to the financial statement, the company expects research and development expenses to decrease substantially in 2024 after completing the CLEAR Outcomes CVOT and submitting regulatory filings to the FDA and EMA in 2023. However, a specific dollar amount for projected R&D expenses is not provided.", "ground_truth": "The financial statement does not provide any projected R&D expenses for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 4, "question": "What is the growth rate of the employees' salaries in 2024?", "prediction": "Based on the provided chunks, there is no specific information about the growth rate of employees' salaries in 2024. The text discusses employee benefits and compensation programs in general, but does not provide details about a salary growth rate for the upcoming year.", "ground_truth": "The financial statement does not mention or provide information on the growth rate of employees' salaries in 2024."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 5, "question": "What are the company's strategies for entering new international markets?", "prediction": "Based on the provided chunks, the company's strategies for entering international markets include:\n\n1. Navigating complex regulatory requirements in different jurisdictions, including:\n- Obtaining regulatory approvals from comparable authorities in foreign countries\n- Completing required clinical trials\n- Complying with country-specific pricing and reimbursement rules\n\n2. Understanding market-specific regulations, such as:\n- Positive and negative list systems for product marketing\n- Cost-effectiveness comparisons for new therapies\n- Monitoring and controlling profit margins\n\n3. Preparing for potential barriers to entry, recognizing that healthcare markets increasingly have high barriers for new products\n\nThe company has already obtained approvals in some regions (EU, Switzerland) for their products NILEMDO and NUSTENDI, indicating an active approach to international market expansion.", "ground_truth": "The document does not mention any strategies for entering new international markets."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": "full", "question": "How many patents does the company hold in Asia for its LDL-C lowering therapies?", "prediction": "I apologize, but there is no information in the provided chunks about the number of patents the company holds in Asia for its LDL-C lowering therapies. The text discusses competitors, market opportunities, and various LDL-C lowering therapies, but does not specify the company's patent portfolio in Asia.", "ground_truth": "The document does not provide information on the number of patents held by the company in Asia for its LDL-C lowering therapies."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 0, "question": "What strategies are in place for managing climate change risks?", "prediction": "Based on the provided chunks, there is no specific information about strategies for managing climate change risks. The text focuses on topics like employee engagement, cybersecurity, and general business risks, but does not mention climate change or related risk management strategies.", "ground_truth": "The financial statement does not mention any strategies for managing climate change risks."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 1, "question": "What percentage of revenue comes from the education vertical market?", "prediction": "Based on the provided chunks, there is no information about revenue from the education vertical market. In fact, chunk 2 only mentions education as a potential future vertical market that the company may seek to penetrate, but has not yet done so.", "ground_truth": "The document does not provide specific information on the percentage of revenue that comes from the education vertical market."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 2, "question": "What are the main strategies the company plans to implement to address potential supply chain disruptions?", "prediction": "Based on the provided chunks, there are no specific detailed strategies mentioned for addressing supply chain disruptions. The text primarily discusses COVID-19 impacts on their insurance referral business and general risk factors. The company acknowledges challenges like pandemic-related disruptions and potential economic uncertainties, but does not outline a specific supply chain resilience strategy.\n\nThe closest reference is their general business approach, which emphasizes:\n1. A capital-efficient business model\n2. Scalable technology platform\n3. Adaptable partnerships with insurance carriers\n4. A culture of innovation and transparency\n\nHowever, these are broad business principles, not targeted supply chain disruption strategies.", "ground_truth": "The document does not specify any main strategies the company plans to implement to address potential supply chain disruptions."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 3, "question": "What is the company's current cash burn rate?", "prediction": "Based on the financial statements provided, the company generated $20.2 million in net cash from operating activities in 2023, which does not indicate a cash burn rate. In fact, the company appears to have positive cash flow. As of December 31, 2023, they had $17.3 million in cash and cash equivalents, and they believe their current liquidity sources will be sufficient to meet their projected operating and debt service requirements for the next twelve months.", "ground_truth": "The financial statement does not specify the company's current cash burn rate."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 4, "question": "What was the company's employee turnover rate for the year 2023?", "prediction": "The text does not provide the specific employee turnover rate for 2023. The passage only mentions the company has a \"low turnover\" rate and values a \"growth-minded team\", but does not quantify the exact turnover percentage.", "ground_truth": "The financial statement does not provide information about the company's employee turnover rate for the year 2023."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 5, "question": "What strategies has the company implemented to expand its market presence internationally?", "prediction": "Based on the provided chunks, there is no specific mention of international market expansion strategies. The text focuses on the company's domestic insurance distribution platform in the United States, with a primary emphasis on expanding within existing and potentially new insurance verticals domestically. The company mentions being open to exploring new verticals that share similar characteristics, but does not discuss international market strategies.", "ground_truth": "The financial statement does not provide information on any strategies that the company has implemented to expand its market presence internationally."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": "full", "question": "What are the company’s plans regarding expansion into international markets?", "prediction": "Based on the provided chunks, there is no mention of plans for international market expansion. The company discusses expanding into new verticals within the insurance market, but does not specifically address international market expansion. Their growth strategy appears focused on domestic market opportunities, such as increasing partner transaction values, improving ecosystem efficiency, and deepening relationships with existing agents.", "ground_truth": "The document does not provide information on the company's plans regarding expansion into international markets."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 0, "question": "What are the projected environmental impacts of the company's production facilities for the next five years?", "prediction": "Based on the provided chunks, there is no specific information about the projected environmental impacts of the company's production facilities for the next five years. Chunk 2 only mentions general environmental, health, and safety regulations and potential risks related to hazardous materials handling, but does not provide a forward-looking environmental impact assessment.", "ground_truth": "The document does not provide any information on the projected environmental impacts of the company's production facilities for the next five years."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 1, "question": "What are the projected sales figures for the new drug in its first year on the market?", "prediction": "I apologize, but there are no projected sales figures mentioned in these financial statement chunks. The text discusses clinical trials, regulatory exclusivity, and patent details for various drug candidates, but does not provide any sales projections or revenue estimates for the first year of market introduction.", "ground_truth": "The document does not provide any projected sales figures for the new drug in its first year on the market."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 2, "question": "What are the specific financial metrics used to evaluate the success of the digital medicine programs?", "prediction": "Based on the provided chunks, there are no specific financial metrics mentioned for evaluating the success of the digital medicine programs. The text describes digital medicine as a complementary effort to their drug development, with project roadmaps and investments contingent on drug program progression, but does not provide quantitative financial evaluation metrics.", "ground_truth": "The document does not provide specific financial metrics used to evaluate the success of the digital medicine programs."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 3, "question": "What are the projected market growth rates for MM120 and MM402 after commercial approval?", "prediction": "Based on the provided chunks, there is no specific information about projected market growth rates for MM120 or MM402 after commercial approval. The documents discuss the clinical development stages of these compounds, but do not provide market growth projections or estimates.", "ground_truth": "The financial statement does not provide any projected market growth rates for MM120 and MM402 after potential commercial approval."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 4, "question": "What is the projected timeline for the launch of MM120 and MM402 in the Asian market?", "prediction": "Based on the provided chunks, there is no specific information about the projected timeline for launching MM120 and MM402 in the Asian market. The chunks discuss clinical trial progress and development strategies, but do not mention a specific launch timeline for Asia.", "ground_truth": "The financial statement does not provide any specific information regarding the projected timeline for the launch of MM120 and MM402 in the Asian market."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 5, "question": "What is the company's strategy for entering the Asian market?", "prediction": "Based on the provided chunks, there is no specific mention of a strategy for entering the Asian market. The strategy sections discuss general goals like advancing their clinical pipeline, commercializing product candidates, and exploring market potential in the UK, EU, and other regions outside the United States, but do not provide details about an Asian market entry strategy.", "ground_truth": "The financial statement does not mention any specific strategy for entering the Asian market."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": "full", "question": "What is the price range for the company's proposed digital health tools?", "prediction": "I apologize, but there is no information in these financial statement excerpts about the pricing of digital health tools. The chunks discuss the company's research and development activities, manufacturing processes, and regulatory considerations, but do not specify any pricing for digital health tools.", "ground_truth": "The financial statement does not mention any price range for the company's proposed digital health tools."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 0, "question": "What strategies does NVIDIA have for acquiring new businesses or technologies?", "prediction": "Based on the provided chunks, NVIDIA's strategies for acquiring new businesses or technologies include:\n\n1. Continuous investment in research and development (over $45.3 billion invested since inception)\n2. Developing or acquiring new products and technologies through R&D investments\n3. Launching new offerings with innovative business models, including:\n   - Software solutions\n   - Cloud services\n   - Platform-as-a-service offerings\n4. Expanding ecosystem for their products and technologies\n5. Exploring new markets with potential for long-term growth, even if they may not produce immediate revenue\n\nThe company emphasizes a platform strategy that integrates hardware, systems, software, algorithms, libraries, and services to create unique value across different markets.", "ground_truth": "The document does not provide specific information on NVIDIA's strategies for acquiring new businesses or technologies."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 1, "question": "What is the company's profit margin in the new generative AI services sector?", "prediction": "Based on the provided financial statement chunks, there is no specific breakdown of the profit margin for NVIDIA's generative AI services sector. The chunks discuss NVIDIA's significant Data Center revenue growth of 217% and overall gross margin increase to 72.7% in fiscal year 2024, but do not provide a precise profit margin specifically for generative AI services. The documents acknowledge the uncertainty around the long-term trajectory of generative AI demand.", "ground_truth": "The document does not provide specific information on the company's profit margin in the new generative AI services sector."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 2, "question": "What are the specific interest rates applied to company's outstanding debt?", "prediction": "According to the financial statement, NVIDIA's outstanding debt has the following interest rates:\n- 0.309% Notes Due 2023 (repaid)\n- 0.584% Notes Due 2024\n- 3.20% Notes Due 2026\n- 1.55% Notes Due 2028\n- 2.85% Notes Due 2030\n- 2.00% Notes Due 2031\n- 3.50% Notes Due 2040\n- 3.50% Notes Due 2050\n- 3.70% Notes Due 2060", "ground_truth": "The financial statement does not provide information on the specific interest rates applied to the company's outstanding debt."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 3, "question": "What are the company's plans for expansion in international markets in the next fiscal year?", "prediction": "Based on the provided chunks, NVIDIA's international market plans for the next fiscal year are somewhat limited. The company notes that while they generated 56% of revenue from international sales in fiscal year 2024, their sales to China have significantly decreased due to U.S. government licensing restrictions. They expect China to represent only a mid-single digit percentage of Data Center revenue in the first quarter of fiscal year 2025 and are shipping alternative products to the China market in small volumes. No specific detailed expansion strategy for other international markets is explicitly outlined in these excerpts.", "ground_truth": "The financial statement does not detail specific plans for expansion in international markets for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 4, "question": "What specific technology developments did NVIDIA invest in during the fiscal year 2024?", "prediction": "Based on the chunks, in fiscal year 2024, NVIDIA invested in several key technology developments:\n\n1. Data Center:\n- AI inference platforms with Ada, Hopper, and Grace Hopper processors\n- NVIDIA DGX Cloud\n- AI Foundations for custom large language models\n- NVIDIA Spectrum-X networking platform\n\n2. Gaming:\n- GeForce RTX 4060 and 4070 GPUs\n- NVIDIA Avatar Cloud Engine for Games\n- DLSS 3.5 Ray Reconstruction\n- TensorRT-LLM for Windows\n\n3. Professional Visualization:\n- New RTX Ada Lovelace architecture GPUs\n- NVIDIA Omniverse Cloud\n\n4. Automotive:\n- Partnership with MediaTek for automotive systems-on-chips with GPU chiplet IP\n\nThese developments span AI, graphics, computing platforms, and various industry sectors.", "ground_truth": "The financial statements do not list specific technology developments that NVIDIA invested in during the fiscal year 2024."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 5, "question": "What are the sustainability initiatives undertaken by the company in fiscal year 2024?", "prediction": "Based on the chunks, here are NVIDIA's key sustainability initiatives in fiscal year 2024:\n\n1. Renewable Energy Goal: Aim to purchase or generate enough renewable energy to match 100% of global electricity usage for offices and data centers by the end of fiscal year 2025. In fiscal year 2023, they matched 44% of electricity use with renewable energy.\n\n2. Supplier Engagement: Goal to engage manufacturing suppliers comprising at least 67% of NVIDIA's scope 3 category 1 GHG emissions, with the objective of encouraging supplier adoption of science-based targets.\n\n3. Energy Efficiency: Continued focus on improving energy efficiency in product design, with 24 of the top 30 most energy-efficient systems on the Green500 list powered by NVIDIA.\n\n4. Climate Change Modeling: Plan to build Earth-2, a digital twin of the Earth using NVIDIA AI and Omniverse platforms to enable climate change impact predictions and mitigation strategies.", "ground_truth": "The document does not provide information on any sustainability initiatives undertaken by the company in fiscal year 2024."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": "full", "question": "What is the projected growth rate for NVIDIA's AI solutions over the next five years?", "prediction": "I apologize, but I cannot find a specific projected growth rate for NVIDIA's AI solutions in the provided financial statement chunks. While the documents discuss NVIDIA's significant AI innovations and investments, they do not provide a concrete numerical forecast for AI solution growth over the next five years.", "ground_truth": "The document does not provide any specific projected growth rate for NVIDIA's AI solutions over the next five years."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 0, "question": "What are the future expansion plans for Paratek Pharmaceuticals in the African market?", "prediction": "Based on the provided chunks, there is no specific information about Paratek Pharmaceuticals' future expansion plans in the African market. The retrieved text discusses the company's current products, licensing agreements, and strategic plans, but does not mention any specific strategies for the African market.", "ground_truth": "The financial document does not provide information regarding the future expansion plans of Paratek Pharmaceuticals in the African market."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 1, "question": "What is the company's strategy for expanding into emerging markets?", "prediction": "Based on the provided chunks, there is no explicit discussion of the company's strategy for expanding into emerging markets. The chunks mainly discuss the company's financial situation, personnel challenges, competitive landscape, and regulatory approval processes. The only potential international reference is a brief mention of developing sarecycline for acne in China, but this does not constitute a comprehensive emerging market expansion strategy.", "ground_truth": "The financial statement does not mention the company's strategy for expanding into emerging markets."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 2, "question": "What is the long-term strategy for SEYSARA's expansion into European markets?", "prediction": "Based on the provided chunks, there is no specific information about SEYSARA's long-term strategy for expansion into European markets. The text primarily discusses SEYSARA's current U.S. and China market status, with Almirall having exclusive commercialization rights in certain regions, but does not mention any European expansion plans.", "ground_truth": "The document does not provide details on a long-term strategy for SEYSARA's expansion into European markets."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 3, "question": "How many employees does the company have?", "prediction": "According to chunk 1, as of February 28, 2023, the company had 268 full-time employees.", "ground_truth": "The document does not provide any information regarding the number of employees the company has."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 4, "question": "What is the company's strategy for expanding into Asian markets for its non-antibiotic products?", "prediction": "Based on the provided chunks, there is no clear strategy mentioned for expanding non-antibiotic products into Asian markets. The documents only discuss SEYSARA (an acne treatment) having a limited license in China, with Almirall planning to submit it to China's NMPA in 2023. The company states they are primarily focused on NUZYRA (an antibiotic) and are not currently developing other product candidates.", "ground_truth": "The financial statement does not provide any information on the company's strategy for expanding into Asian markets for its non-antibiotic products."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 5, "question": "What is the company's strategy for expanding into emerging markets?", "prediction": "Based on the provided chunks, there is no explicit discussion of the company's strategy for expanding into emerging markets. The chunks mostly discuss the company's financial challenges, personnel issues, competitive landscape, regulatory processes, and healthcare pricing complexities. The only international reference is a brief mention of potentially developing sarecycline for acne in China, but this does not constitute a comprehensive emerging market expansion strategy.", "ground_truth": "The financial statement does not discuss any strategies for expanding into emerging markets."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": "full", "question": "What is the specific tax impact of international operations on the company's financials?", "prediction": "Based on the financial statement chunks, the tax impact of international operations is minimal. The tax reconciliation shows a small \"(0.07)%\" impact from foreign withholding taxes in 2022, related to the Zai Collaboration Agreement. The company's tax provision primarily reflects domestic tax considerations, with a full valuation allowance against deferred tax assets due to historical net operating losses.", "ground_truth": "The financial statement does not provide information about the specific tax impact of international operations on the company's financials."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 0, "question": "How many patents did Tesla file in the year 2023?", "prediction": "I apologize, but I cannot find specific information in the provided chunks about the number of patents Tesla filed in 2023. The chunks discuss Tesla's intellectual property approach and strategy, but do not provide a specific count of patents filed in 2023.", "ground_truth": "The document does not provide information on the number of patents Tesla filed in the year 2023."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 1, "question": "What is the projected growth rate for Tesla's solar energy systems installations in 2024?", "prediction": "Based on the provided chunks, there is no specific projection for Tesla's solar energy systems installations in 2024. The financial statement mentions that in 2023, Tesla deployed 223 megawatts of solar energy systems, and they are focused on improving Solar Roof installation capability and efficiency, but no explicit growth rate for 2024 is stated.", "ground_truth": "The financial statement does not mention the projected growth rate for Tesla's solar energy systems installations in 2024."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 2, "question": "What sustainable energy initiatives is the company planning to implement in 2024?", "prediction": "Based on the chunks, here are Tesla's sustainable energy initiatives for 2024:\n\n1. Continue expanding Supercharger network, including opening network to non-Tesla vehicles in phases\n\n2. Launch an Employee Educational Assistance Program to help employees pursue certificates/degrees\n\n3. Continue building factories with increased sustainability focus, including:\n- Reducing per-unit waste\n- Reducing resource consumption\n- Reducing carbon footprint in supply chain\n\n4. Grow their graduate hiring program, targeting over 600 students across different Gigafactories\n\n5. Launch an Engineering Development Program in collaboration with Austin Community College to train engineers in high-demand manufacturing technologies\n\nThese initiatives align with Tesla's core mission of accelerating the world's transition to sustainable energy.", "ground_truth": "The financial statement does not mention any specific sustainable energy initiatives planned for implementation in 2024."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 3, "question": "What are the competitive strategies Tesla has implemented to enhance its market positioning?", "prediction": "Based on the provided chunks, Tesla has implemented several competitive strategies:\n\n1. Sustainability Focus:\n- Building more efficient and sustainable factories\n- Responsible material sourcing\n- Reducing carbon footprint in supply chain\n\n2. Human Capital Strategy:\n- Attracting high-quality employees\n- Offering internal career development\n- Providing competitive benefits (stock ownership, health benefits)\n- Continuous leadership training\n\n3. Sales and Marketing Approach:\n- Direct sales through website and company-owned stores\n- Low-cost marketing\n- Customer education\n- Integrated used vehicle sales supporting new vehicle transactions\n\n4. Global Manufacturing Expansion:\n- Localizing vehicle designs for specific markets\n- Optimizing factories for local workforces\n- Investing in automation and advanced simulation technologies\n\n5. Innovative Product Offerings:\n- Customizable energy generation and storage solutions\n- Expanding Supercharger network\n- Modular product designs (e.g., Megapack battery)\n\nThese strategies collectively aim to differentiate Tesla through technology, sustainability, workforce excellence, and customer-centric approaches.", "ground_truth": "The financial statement does not provide information on specific competitive strategies Tesla has implemented to enhance its market positioning."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 4, "question": "What are the projected costs for expanding the automation facilities within the next five years?", "prediction": "Based on the provided financial statement chunks, Tesla expects capital expenditures to exceed $10 billion in 2024 and be between $8-10 billion in each of the following two fiscal years. Specifically for the Gigafactory New York, they have an agreement to spend or incur $5 billion in combined capital, operational expenses, and other costs through December 31, 2029. However, the exact costs specifically for automation facilities are not explicitly detailed in these chunks.", "ground_truth": "The financial statement does not provide information regarding the projected costs for expanding the automation facilities within the next five years."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 5, "question": "What is the projected revenue growth rate for Tesla's energy generation and storage segment over the next five years?", "prediction": "I apologize, but I cannot find specific information in these financial statement chunks about Tesla's projected revenue growth rate for the energy generation and storage segment over the next five years. The chunks only provide historical revenue data for this segment (showing a 54% increase from 2022 to 2023), but do not include future projections.", "ground_truth": "The document does not provide information on the projected revenue growth rate for Tesla's energy generation and storage segment over the next five years."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": "full", "question": "How much of Tesla's revenue in 2023 was derived from partnerships with other automotive manufacturers?", "prediction": "I apologize, but after carefully reviewing the provided financial statement chunks, there is no information indicating any revenue from automotive manufacturing partnerships. The revenue breakdown shows Tesla's own automotive sales, regulatory credits, and leasing revenue, but does not mention revenue from partnerships with other automotive manufacturers.", "ground_truth": "The document does not specify how much of Tesla's revenue in 2023 was derived from partnerships with other automotive manufacturers."}
